Tetrandrine inhibits the proliferation of human osteosarcoma cells by upregulating the PTEN pathway

Tian,Dong-Dong; Zhang,Ran-Xi; Wu,Nian; Yuan,Wei; Luo,Shuai-Hong; Chen,Hou‑Qing; Liu,Yang; Wang,Yang; He,Bai-Cheng; Deng,Zhong-Liang

doi:10.3892/or.2017.5560

Tetrandrine inhibits the proliferation of human osteosarcoma cells by upregulating the PTEN pathway

Authors:
- Dong-Dong Tian
- Ran-Xi Zhang
- Nian Wu
- Wei Yuan
- Shuai-Hong Luo
- Hou‑Qing Chen
- Yang Liu
- Yang Wang
- Bai-Cheng He
- Zhong-Liang Deng
View Affiliations

Affiliations: Department of Orthopaedics, The Second Affiliated Hospital, Chongqing Medical University, Yuzhong, Chongqing 400010, P.R. China, Chongqing Key Laboratory of Biochemistry and Molecular Pharmacology, Chongqing Medical University, Yuzhong, Chongqing 400010, P.R. China
Published online on: April 6, 2017 https://doi.org/10.3892/or.2017.5560
Pages: 2795-2802

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Tetrandrine (TET) is a natural product isolated from the Chinese herb Stephania tetrandra S. Moore and has been reported to have antiproliferation and apoptosis-inducing activity in various malignant tumor cells. However, the exact molecular mechanisms underlying these effects remain unclear. In the present study, we tested the antiproliferation effect of TET on osteosarcoma (OS) 143B cells and explored the possible potential molecular mechanism in this process. Using CCK-8 assay and flow cytometry, we found that TET inhibited proliferation, induced apoptosis and arrested the cell cycle of the 143B cells. Using a xenograft tumor model of human OS, tetrandrine was found to inhibit tumor growth in vivo. TET increased the protein level of phosphatase and tensin homolog (PTEN) and decreased its phosphorylation as detected by western blot analysis and immunohistochemistry.Overexpression of PTEN strengthened the anticancer effect of TET, while knockdown of PTEN attenuated it. Meanwhile, TET activated p38 MAPK and increased its phosphorylation. Our findings suggest that TET may be a potential anticancer drug for OS. In addition, its effects may be mediated by the upregulation of PTEN. Moreover the expression alteration of PTEN and p-PTEN was mediated by the TET-induced activation of p38 MAPK in a direct or indirect manner.

View Figures

View References

1	Wan G, Tao JG, Wang GD, Liu SP, Zhao HX and Liang QD: In vitro antitumor activity of the ethyl acetate extract of Potentilla chinensis in osteosarcoma cancer cells. Mol Med Rep. 14:3634–3640. 2016.PubMed/NCBI
2	Meng ZJ, Wu N, Liu Y, Shu KJ, Zou X, Zhang RX, Pi CJ, He BC, Ke ZY, Chen L, et al: Evodiamine inhibits the proliferation of human osteosarcoma cells by blocking PI3K/Akt signaling. Oncol Rep. 34:1388–1396. 2015.PubMed/NCBI
3	Scholten DJ II, Timmer CM, Peacock JD, Pelle DW, Williams BO and Steensma MR: Down regulation of Wnt signaling mitigates hypoxia-induced chemoresistance in human osteosarcoma cells. PLoS One. 9:e1114312014. View Article : Google Scholar : PubMed/NCBI
4	Pruksakorn D, Teeyakasem P, Klangjorhor J, Chaiyawat P, Settakorn J, Diskul-Na-Ayudthaya P, Chokchaichamnankit D, Pothacharoen P and Srisomsap C: Overexpression of KH-type splicing regulatory protein regulates proliferation, migration, and implantation ability of osteosarcoma. Int J Oncol. 49:903–912. 2016.PubMed/NCBI
5	Ma K, Huang MY, Guo YX and Hu GQ: Matrine-induced autophagy counteracts cell apoptosis via the ERK signaling pathway in osteosarcoma cells. Oncol Lett. 12:1854–1860. 2016.PubMed/NCBI
6	Sarman H, Bayram R and Benek SB: Anticancer drugs with chemotherapeutic interactions with thymoquinone in osteosarcoma cells. Eur Rev Med Pharmacol Sci. 20:1263–1270. 2016.PubMed/NCBI
7	Wei X, Qu TL, Yang YF, Xu JF, Li XW, Zhao ZB and Guo YW: Design and synthesis of new tetrandrine derivatives and their antitumor activities. J Asian Nat Prod Res. 18:966–975. 2016. View Article : Google Scholar : PubMed/NCBI
8	Liu T, Liu X and Li W: Tetrandrine, a Chinese plant-derived alkaloid, is a potential candidate for cancer chemotherapy. Oncotarget. 7:40800–40815. 2016.PubMed/NCBI
9	Lei RR, Hu HF, Bai F, Liu Y, Wu CZ, Huang XX, Xie LP and Hu YJ: Anti-proliferative and apoptotic effects of S1, a tetrandrine derivative, in human gastric cancer BGC-823 cells. Chin J Nat Med. 14:527–533. 2016.PubMed/NCBI
10	Zhang Y, Liu W, He W, Zhang Y, Deng X, Ma Y, Zeng J and Kou B: Tetrandrine reverses epithelial-mesenchymal transition in bladder cancer by downregulating Gli-1. Int J Oncol. 48:2035–2042. 2016.PubMed/NCBI
11	Li D, Lu Y, Sun P, Feng LX, Liu M, Hu LH, Wu WY, Jiang BH, Yang M, Qu XB, et al: Inhibition on proteasome β1 subunit might contribute to the anti-cancer effects of fangchinoline in human prostate cancer cells. PLoS One. 10:e01416812015. View Article : Google Scholar : PubMed/NCBI
12	Wu K, Zhou M, Wu QX, Yuan SX, Wang DX, Jin JL, Huang J, Yang JQ, Sun WJ, Wan LH, et al: The role of IGFBP-5 in mediating the anti-proliferation effect of tetrandrine in human colon cancer cells. Int J Oncol. 46:1205–1213. 2015.PubMed/NCBI
13	Zhu R, Liu T, Tan Z, Wu X, Li M, Jiang L, Bao R, Shu Y, Lu A and Liu Y: Tetrandrine induces apoptosis in gallbladder carcinoma in vitro. Int J Clin Pharmacol Ther. 52:900–905. 2014. View Article : Google Scholar : PubMed/NCBI
14	Tian Y, Yin H and Xu H: Enhanced pro-apoptotic effect of tetrandrine loaded nanoparticles against osteosarcoma cells. Curr Drug Deliv. 13:946–952. 2016. View Article : Google Scholar : PubMed/NCBI
15	Tao LJ, Zhou XD, Shen CC, Liang CZ, Liu B, Tao Y and Tao HM: Tetrandrine induces apoptosis and triggers a caspase cascade in U2-OS and MG-63 cells through the intrinsic and extrinsic pathways. Mol Med Rep. 9:345–349. 2014.PubMed/NCBI
16	Shojaee S, Chan LN, Buchner M, Cazzaniga V, Cosgun KN, Geng H, Qiu YH, von Minden MD, Ernst T, Hochhaus A, et al: PTEN opposes negative selection and enables oncogenic transformation of pre-B cells. Nat Med. 22:379–387. 2016. View Article : Google Scholar : PubMed/NCBI
17	Liu YL and Yan Y: Timing of the loss of Pten protein determines disease severity in a mouse model of myeloid malignancy. 127:1912–1922. 2016.
18	Johnson GL and Lapadat R: Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science. 298:1911–1912. 2002. View Article : Google Scholar : PubMed/NCBI
19	Banerjee B, Nandi P, Chakraborty S, Raha S, Sen PC and Jana K: Resveratrol ameliorates benzo(a)pyrene-induced testicular dysfunction and apoptosis: Involvement of p38 MAPK/ATF2/iNOS signaling. J Nutr Biochem. 34:17–29. 2016. View Article : Google Scholar : PubMed/NCBI
20	Li J, Zhang J, Tang M, Xin J, Xu Y, Volk A, Hao C, Hu C, Sun J, Wei W, et al: Hematopoietic stem cell activity is regulated by Pten phosphorylation through a niche-dependent mechanism. Stem Cells. 34:2130–2144. 2016. View Article : Google Scholar : PubMed/NCBI
21	Wu QX, Yuan SX, Ren CM, Yu Y, Sun WJ, He BC and Wu K: Oridonin upregulates PTEN through activating p38 MAPK and inhibits proliferation in human colon cancer cells. Oncol Rep. 35:3341–3348. 2016.PubMed/NCBI
22	Luo J, Deng ZL, Luo X, Tang N, Song WX, Chen J, Sharff KA, Luu HH, Haydon RC, Kinzler KW, et al: A protocol for rapid generation of recombinant adenoviruses using the AdEasy system. Nat Protoc. 2:1236–1247. 2007. View Article : Google Scholar : PubMed/NCBI
23	Rhei E, Kang L, Bogomolniy F, Federici MG, Borgen PI and Boyd J: Mutation analysis of the putative tumor suppressor gene PTEN/MMAC1 in primary breast carcinomas. Cancer Res. 57:3657–3659. 1997.PubMed/NCBI
24	Wang L, Wang W, Rui Z and Zhou D: The effective combination therapy against human osteosarcoma: Doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system. Drug Deliv. 23:3200–3208. 2016. View Article : Google Scholar : PubMed/NCBI
25	Bhagya N and Chandrashekar KR: Tetrandrine - A molecule of wide bioactivity. Phytochemistry. 125:5–13. 2016. View Article : Google Scholar : PubMed/NCBI
26	Xiao W, Jiang Y, Men Q, Yuan L, Huang Z, Liu T, Li W and Liu X: Tetrandrine induces G1/S cell cycle arrest through the ROS/Akt pathway in EOMA cells and inhibits angiogenesis in vivo. Int J Oncol. 46:360–368. 2015.PubMed/NCBI
27	Chiou WF, Lee WS and Yeh PH: Tetrandrine selectively protects against amyloid-beta protein - but not against MPTP-induced cytotoxicity in SK-N-SH neuroblastoma cells. Planta Med. 72:1300–1304. 2006. View Article : Google Scholar : PubMed/NCBI
28	Shen YC, Chen CF, Wang SY and Sung YJ: Impediment to calcium influx and reactive oxygen production accounts for the inhibition of neutrophil Mac-1 Up-regulation and adhesion by tetrandrine. Mol Pharmacol. 55:186–193. 1999.PubMed/NCBI
29	Oh SH and Lee BH: Induction of apoptosis in human hepatoblastoma cells by tetrandrine via caspase-dependent Bid cleavage and cytochrome c release. Biochem Pharmacol. 66:725–731. 2003. View Article : Google Scholar : PubMed/NCBI
30	Xu M, Sheng LH, Zhu XH, Zeng SB and Zhang GJ: Reversal effect of Stephania tetrandra-containing Chinese herb formula SENL on multidrug resistance in lung cancer cell line SW1573/2R120. Am J Chin Med. 38:401–413. 2010. View Article : Google Scholar : PubMed/NCBI
31	Xing ZB, Yao L, Zhang GQ, Zhang XY, Zhang YX and Pang D: Fangchinoline inhibits breast adenocarcinoma proliferation by inducing apoptosis. Chem Pharm Bull. 59:1476–1480. 2011. View Article : Google Scholar : PubMed/NCBI
32	Chaudhary P and Vishwanatha JK: c-Jun NH₂-terminal kinase-induced proteasomal degradation of c-FLIP_L/S and Bcl₂ sensitize prostate cancer cells to Fas- and mitochondria-mediated apoptosis by tetrandrine. Biochem Pharmacol. 91:457–473. 2014. View Article : Google Scholar : PubMed/NCBI
33	Fallahabadi ZR, Daloii Noori MR, Mahdian R, Behjati F, Shokrgozar MA, Abolhasani M, Asgari M and Shahrokh H: Frequency of PTEN alterations, TMPRSS2-ERG fusion and their association in prostate cancer. Gene. 575:755–760. 2016. View Article : Google Scholar : PubMed/NCBI
34	Liang N, Zhou X, Zhao M, Zhao D, Zhu Z, Li S and Yang H: Down-regulation of microRNA-26b modulates non-small cell lung cancer cells chemoresistance and migration through the association of PTEN. Acta Biochim Biophys Sin. 47:530–538. 2015. View Article : Google Scholar : PubMed/NCBI
35	Mi S, Xiang G, Yuwen D, Gao J, Guo W, Wu X, Wu X, Sun Y, Su Y, Shen Y, et al: Inhibition of autophagy by andrographolide resensitizes cisplatin-resistant non-small cell lung carcinoma cells via activation of the Akt/mTOR pathway. Toxicol Appl Pharmacol. 310:78–86. 2016. View Article : Google Scholar : PubMed/NCBI
36	Xiong J, Li Z, Zhang Y, Li D, Zhang G, Luo X, Jie Z, Liu Y, Cao Y, Le Z, et al: PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN. Oncol Rep. 36:1819–1828. 2016.PubMed/NCBI
37	Šrámek J, Němcová-Fürstová V and Kovář J: Kinase signaling in apoptosis induced by saturated fatty acids in pancreatic β-cells. Int J Mol Sci. 17:172016. View Article : Google Scholar
38	Segalés J, Perdiguero E and Muñoz-Cánoves P: Regulation of muscle stem cell functions: A focus on the p38 MAPK signaling pathway. Front Cell Dev Biol. 4:912016. View Article : Google Scholar : PubMed/NCBI
39	Wang L, Bai YY, Yang Y, Hu F, Wang Y, Yu Z, Cheng Z and Zhou J: Diabetes mellitus stimulates pancreatic cancer growth and epithelial-mesenchymal transition-mediated metastasis via a p38 MAPK pathway. Oncotarget. 7:38539–38550. 2016.PubMed/NCBI
40	Su CC, Chen JY, Din ZH, Su JH, Yang ZY, Chen YJ, Wang RY and Wu YJ: 13-acetoxysarcocrassolide induces apoptosis on human gastric carcinoma cells through mitochondria-related apoptotic pathways: p38/JNK activation and PI3K/AKT suppression. Mar Drugs. 12:5295–5315. 2014. View Article : Google Scholar : PubMed/NCBI
41	Benvenuto M, Mattera R, Masuelli L, Taffera G, Andracchio O, Tresoldi I, Lido P, Giganti MG, Godos J, Modesti A, et al: (±)-Gossypol induces apoptosis and autophagy in head and neck carcinoma cell lines and inhibits the growth of transplanted salivary gland cancer cells in BALB/c mice. Int J Food Sci Nutr. 1–15. 2016.